Organization of actin filaments into a well-organized sarcomere structure is critical for muscle development and function. However, it is not completely understood how sarcomeric actin/ thin filaments attain their stereotyped lengths. In an RNAi screen in Drosophila primary muscle cells, we identified a gene, sarcomere length short (sals), which encodes an actin-binding, WH2 domain-containing protein, required for proper sarcomere size. When sals is knocked down by RNAi, primary muscles display thin myofibrils with shortened sarcomeres and increased sarcomere number. Both loss-and gain-of-function analyses indicate that SALS may influence sarcomere lengths by promoting thin-filament lengthening from pointed ends. Furthermore, the complex localization of SALS and other sarcomeric proteins in myofibrils reveals that the full length of thin filaments is achieved in a two-step process, and that SALS is required for the second elongation phase, most likely because it antagonizes the pointed-end capping protein Tropomodulin.
INTRODUCTION
Striated muscles in both insects and vertebrates have remarkably regular and precise organizations that are intimately linked to their function. Sarcomeres, the basic contractile units of myofibrils in muscles, are composed of actin (thin) and myosin (thick) filaments and their associated proteins ( Figure 1A ). Interestingly, although the length of thin filaments is strikingly uniform within individual sarcomeres, there are significant differences in the absolute length of thin filaments in different muscle types of the same animal (Granzier et al., 1991) as well as in muscles of different species (Page and Huxley, 1963) . Furthermore, variations in thin-filament length are believed to be responsible for the distinct mechanical properties characteristic of each muscle (Burkholder et al., 1994) , because the thick-filament length is fairly constant (Page and Huxley, 1963) . According to the crossbridge theory of muscle contraction (Huxley and Simmons, 1971) , the extent of overlap between thin and thick filaments determines the amount of force that a muscle can exert at different sarcomere lengths. Finally, abnormal thin-filament lengths are thought to be the molecular basis for several debilitating muscle diseases, such as nemaline myopathy and dilated cardiomyopathy (Littlefield and Fowler, 1998; Sussman et al., 1999) . Thus, the precise regulation of thin-filament length is critical for muscle function and muscle integrity.
Sarcomeric actin filaments are organized with their two ends lined up in regular arrays ( Figure 1A ). The barbed (plus) ends are capped by CapZ and are crosslinked by a-actinin at the Z line. Tropomodulin (Tmod), another capping protein, binds to the free pointed (minus) ends located in the middle of the sarcomere toward the H zone, a region free of thin filaments. In nonmuscle cells, it is generally believed that most, if not all, actin assembly is regulated at the barbed ends, and that pointed ends are the sites of disassembly (i.e., treadmilling process) (Pollard et al., 2000) . Thus, barbed-end and pointed-end capping proteins are thought to influence filament lengths in nonmuscle cells by terminating growth at the barbed ends and by preventing shortening at the pointed ends, respectively (Fischer and Fowler, 2003) . In contrast, the length of sarcomeric actin filaments in striated muscles is primarily regulated by modulation of the pointed-end capping activity of Tmod (Fischer and Fowler, 2003) . Excess Tmod in striated muscles causes shortening of thin filaments (Littlefield et al., 2001; Mardahl-Dumesnil and Fowler, 2001; Sussman et al., 1998) . Conversely, inhibition of Tmod expression or function results in lengthening of thin filaments (Gregorio et al., 1995; Sussman et al., 1998) . Thus, unlike capping proteins in nonmuscle cells, which prevent disassembly, Tmod limits actin assembly at the pointed ends of thin filaments. This may be due to the high actin concentration and highly stable actin arrays in muscle tissues. These observations strongly suggest that thin filaments can elongate from pointed ends (Littlefield et al., 2001; Mardahl-Dumesnil and Fowler, 2001; Sussman et al., 1998) . In addition to Tmod, several other proteins are also involved in the regulation of thin-filament length. Tropomyosin (TM) stabilizes thin filaments by copolymerizing with them and by modulating Tmod binding affinity to the pointed ends (Littlefield and Fowler, 1998) . The actindepolymerizing factor (ADF)/cofilin regulates thin-filament depolymerization from their pointed ends (Mohri et al., 2006) , and nebulin may act as a molecular ruler that (Rescue) (5 days at 25 C). These features include sarcomere length, myofibril length, and myofibril width, all of which are normalized with control lacZ RNAi myofibrils. The length of the sarcomeres was determined by measuring the distance between Z lines. The lengths of sarcomeres in myofibrils of sals RNAi and actin RNAi and the sals mutant are 1.77 ± 0.042 mm (average ± SEM) (range from 1.36 to 2.27 mm), 1.74 ± 0.08 mm (range from 1.30 to 2.38 mm), and 1.70 ± 0.075 mm (range from 1.30 to 2.15 mm), respectively, which are much shorter than the control sarcomere length (6 ± 0.73 mm [range from 4.56 to 7.9 mm]) and that of Rescue myofibrils (5.5 ± 0.06 mm; range from 2.4 to 6.7 mm). The width of myofibrils from both sals and actin RNAi and the sals mutant was 20% of controls (p < 0.01). The width of Rescue myofibrils is comparable to that of lacZ RNAi controls. Both the lengths of myofibrils and the number of sarcomeres in myofibrils were calculated and normalized by the number of muscle nuclei. The average myofibril length (per nucleus) is 60 ± 5 mm for sals RNAi myofibrils, versus 54 ± 4 mm for controls. n R 15 primary muscles with visual phenotypes scored in each of three independent experiments.
dictates thin-filament lengths in vertebrates (Bang et al., 2006; McElhinny et al., 2005; Witt et al., 2006) . Despite the fact that the above-mentioned proteins are linked to either capping, stabilization, or depolymerization of thin filaments, the protein(s) responsible for promoting filament elongation remains unknown.
To identify additional regulators of sarcomere assembly, we developed a screening strategy based on RNA interference (RNAi) in Drosophila primary muscle cells (J.B. et al., unpublished data) . Here, we report the characterization of Sarcomere Length Short (SALS), a novel actinbinding, WH2-containing protein identified by using this approach. Loss of SALS causes shortening of thin filaments and lack of actin incorporation at their pointed ends. Our analyses reveal that SALS promotes thin-filament lengthening from the pointed ends, most likely by antagonizing Tmod capping activity.
RESULTS

Primary Muscle Phenotypes Caused by the Disruption of sals by RNAi
Our protocol for RNAi screening in primary muscle cells (see Experimental Procedures) is based on the ability of cultured myoblasts isolated from Drosophila gastrulating embryos (4-6 hr after egg laying [AEL] ) to fuse and differentiate into striated muscles in the same sequence of developmental events as observed in vivo (Bernstein et al., 1978) . Simply bathing primary cells in medium containing dsRNAs knocks down gene expression in primary muscles (J.B. et al., unpublished data) ( Figure 2I ).
Using this method, we identified CG31374 (FBgn0051374), which we named ''sarcomere length short (sals)'' based on the striking myofibril phenotypes caused by RNAi. In primary cultures treated with dsRNAs against sals (referred to as ''sals RNAi'' in the text), we observed three distinct phenotypes ( Figures 1B and 1C) . First, sals RNAi myofibrils contained much shortened sarcomeres (the lengths of sarcomeres were only 30% of lacZ RNAi controls). Second, these myofibrils were much thinner. These phenotypes were also observed when primary muscles were treated with dsRNAs simultaneously targeting all actin isoforms (referred to as ''actin RNAi'') ( Figures  1B and 1C) , which may reflect an arrest in myofibril assembly due to a lack of actin building blocks. Third, sals RNAi myofibrils possessed more sarcomeres than controls, with an average of 35 and 9 per nucleus, respectively (p < 0.001). Interestingly, the lengths of control versus sals RNAi myofibrils were comparable (Figures 1B and 1C) . This is in contrast to actin RNAi myofibrils, which do not exhibit an increase in sarcomere numbers (7.5 versus 9/per nucleus in controls), thus resulting in a shorter myofibril length ( Figures 1B and 1C) . Finally, sals RNAi muscles contained 3.46 ± 0.062 (average ± SEM) nuclei per fiber, which was comparable to the numbers in controls (3.48 ± 0.5), suggesting that the phenotype that we observed in sals RNAi myofibrils does not result from fewer fusion events.
Molecular Characterization of SALS sals maps to the cytological position 86E5-86E6 ( Figure S1 ; see the Supplemental Data available with this article online). It encodes three transcripts, CG31374-RA, CG31374-RB, and CG31374-RC, derived from alternatively spliced RNAs (Figure 2A ). CG31374-RA encodes a 497 amino acid (aa) protein (SALS-PA, the short form of SALS), whereas CG31374-RB and CG31374-RC encode the same 899 aa protein (the long form of SALS) (Figure 2B ). Both SMART and Pfam searches indicate that the long form of SALS contains two related 10 aa domains (KLRHVACNDR in D1 and KLKPTKTNDR in D2) ( Figures  2B and 2C ), corresponding to an actin-binding motif known as Wiskott-Aldrich syndrome protein (WASP)-homology domain 2 (WH2). WH2 is a phylogenetically conserved domain found in a variety of proteins from yeast to human, including verprolin, N-WASP, and WIP (Paunola et al., 2002) . The SALS long form also contains a profilinbinding proline (Pro)-rich sequence located proximal to the WH2 motifs ( Figure 2B ). This arrangement is similar to that found in verprolin, N-WASP, and WIP, and it has been proposed to be involved in actin-filament elongation (Chereau et al., 2005) . The shorter form, SALS-PA, lacks most of the N terminus of the long form, including the Pro-rich domain and the first WH2 domain (D1).
Whole-mount in situ hybridizations with antisense probes, individually targeting CG31374-RA or CG31374-RB specifically, showed that only the long splice form is expressed during embryogenesis and is restricted to muscles ( Figures 2D-2H ). Its expression initiates at late stage 13 ( Figure 2E ) and strengthens from stage 15 onward (Figures 2F and 2G) . In addition, only dsRNAs targeting the long sals isoform induce muscle phenotypes in primary cultures (Figures 2A and 2I and data not shown) . Immunostaining of larval tissues with two different antibodies targeting different regions of SALS (anti-SALS-Bai targets both isoforms, and anti-SALS-Ma [Ma et al., 2006] only targets the long form) revealed that the short form can be found in nonmuscle tissues such as fat body, whereas the long form is only expressed in muscle tissues during larval stages (data not shown).
PBac{WH}f07849
Insertion Produces a Protein Null Allele of sals PBac{WH}f07849, is a piggyBac transposon inserted at the sals locus (Thibault et al., 2004 (Figures 2I-2K) . Third, remobilization of the piggyBac element from PBac{WH}f07849 by using the piggyBac transposase fully rescued the lethality phenotype. Fourth, primary muscles, derived from sals mutant embryos, showed similar phenotypes to those associated with sals RNAi ( Figure 1C ). Finally, expression of the long form of SALS in primary muscles by using the muscle Gal4 driver Dmef2-Gal4 was able to rescue sals mutant myofibril phenotypes in primary cultures ( Figure 1C ).
Muscle Defects in sals Mutant Animals
To confirm that the myofibril phenotypes associated with sals RNAi in primary muscle cells reflect the function of the gene in vivo, we examined the muscle defects in homozygous sals f07849 mutants at different developmental stages by using a number of muscle markers. At stage 16, sals mutant embryos have normal muscle morphology overall ( Figure S2A ), and the number of nuclei in mutant muscles is comparable to that in their WT counterparts ( Figure S2B ), showing that sals function is not involved in early critical events of muscle development, such as myoblast specification or fusion. WT muscles do not become mature with well-assembled myofibrils until late stage 17 (19-21 hr AEL) (Newman and Wright, 1981) . We therefore examined the staining patterns of actin and the sarcomere Z line protein a-actinin in somatic body wall, pharyngeal, and visceral gut muscles of late-stage-17 sals mutants ( Figures 3A-3C ). Although myofibrils in both WT and mutant muscles showed striated sarcomeric patterns at this stage, muscles in mutant embryos contained myofibrils with numerous short sarcomeres, a finding analogous to that observed in myofibrils in primary cultures from either sals RNAi or sals mutant embryos. The primary difference was the degree of reduction in sarcomere length, which was less severe in mutant animals compared to sals RNAi muscles grown in culture (27% reduction versus 70%) (see Discussion). In addition, whereas WT muscle myofibrils were bundled transversely, mutant myofibrils were thin and split and were distributed along the lateral sides of muscles ( Figure 3A) . Furthermore, the nuclei in mutant muscles were localized more toward the muscle ends rather than evenly distributed, as observed for nuclei in WT muscles ( Figure 3A ; see Figure S3 and its legend). We further examined the muscle structure of ''posthatched'' sals mutants. WT larval somatic muscles at 28-30 hr AEL displayed a well-organized myofibril structure, and they were still growing longitudinally, as 
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(A-C) Confocal fluorescence micrographs of (A) somatic body wall muscles VL3 and VL4, (B) pharyngeal muscle, and (C) visceral muscle from embryos of late stage 17 (19-21 hr AEL), which were visualized for F-actin, for a-actinin, and for nuclei by DAPI staining. The image in the top right panel of (A) shows the same muscles as those in the three top panels on its left, but on a focal plane closer to the muscle periphery. White arrows in (A) point to the termini of muscle VL3. Control sarcomeres in somatic body wall muscle VL3 at A3 averaged 7.7 ± 0.34 mm in length (range from 6.17 to 9.6 mm, n = 12 embryos), whereas sals-deficient sarcomeres averaged 5.59 ± 0.45 mm in length (range from 3.4 to 6.9 mm, n = 12) in vivo. (D) Confocal fluorescence micrographs of somatic body wall muscles VL3 and VL4 from WT larvae (top panel) and posthatching sals mutant embryos (bottom two panels) at 28-30 hr AEL, visualized for F-actin. The scale bars are 10 mm.
evidenced by the increased number of sarcomeres in myofibrils (12 compared to 8 at 19-21 hr AEL) (upper panel in Figure 3D ). In contrast, the muscles of age-matched sals mutant larvae had many more sarcomeres (18 compared to 12 in controls at 28-30 hr AEL), but they were much shorter in length longitudinally (only 70% of their WT counterparts) (middle panel of Figure 3D ), indicating that the growth rate of sals mutant muscles is much slower than that of WT. In addition, some muscles showed a complete disruption of myofibril morphology (bottom panel in Figure 3D ) (see Discussion). This extreme phenotype was also evident under an electron microscopy (EM) analysis ( Figures 4I and 4J) . Interestingly, the numerous electron-dense patches seen under EM (arrowheads in Figure 4J ) resemble the condensed thin filaments in conjunction with Z line materials seen in nemaline myopathy (Yamaguchi et al., 1978) .
Because sals mutants failed to hatch from the egg case, we tested whether this was a result of their inability to move. Peristaltic movement, a characteristic behavior observed before hatching, was detectable in mutant embryos at late stage 17 (20-22 hr AEL at 25 C) (Movie S2). However, compared to control embryos, which exhibit well-coordinated waves of strong forward and backward peristalsis (Movie S1), sals mutants had less frequent backward peristalsis, and the vigor of their contraction was much reduced ( Figure S4 ; Movie S2). At 28-30 hr AEL, which was beyond the expected hatch time, mutants displayed weak movements (Movie S3). They eventually died in the egg case within a day. When mutant animals were released from their egg case by manual dissection, they were flaccid and immobile. We conclude that although sals mutant embryos can move, they cannot generate sufficient contractile force to escape ) at stages of (E-H) 20-22 hr AEL or (I and J) 28-30 hr AEL. (E and F) Transverse sections at a higher magnification show that the basic contractile unit of a thick filament (large black dots) surrounded by an array of thin filaments (small dots) can form correctly in both (E) WT and (F) sals mutant myofibrils. Longitudinal sections of (G) WT muscles and (H) muscles of some mutant embryos (n = 10) show regular, parallel, highly ordered arrays of myofilaments with apparent interdigitating thin and thick filaments (arrows) and well-organized Z lines (arrowheads) that are characteristic of larval muscles. Sarcomeres are in a contracted state in both (G) and (H), and they are 4.5 mm and 3.2 mm long, respectively. Glycogen granules (g), mitochondria (M), and nuclei (N) are also labeled in (G) and (H). (I and J) Sarcomeric regions in muscles of an (I) older WT and (J) mutant embryos (28-30 hr AEL). (J) Note that mutants contain electron-dense structures (black arrowheads), and their myofibrillar architecture was severely disrupted. The scale bar is 10 mm in (A) for (A)-(D), 100 nm in (E) for (E) and (F), 500 nm in (G) for (G) and (H), and 500 nm in (I) for (I) and (J).
Figure 5. SALS Interacts with Actin and Has a Complex Localization in Myofibrils
(A) GST pull-down assays for interactions between SALS and actin. Equal amounts of proteins derived from the indicated GST and GST-SALS constructs (10 mg) were incubated with 0.05 mm G-actin. (B) Cosedimentation assays of SALS binding to gelsolin-capped F-actin. Purified, recombinant full-length SALS (black arrow) cosedimented with F-actin (asterisk) (lane 2), but not by itself (lane 1). (C) Effect of recombinant SALS on nucleated actin assembly. Rabbit skeletal muscle actin was polymerized in the absence or presence of human plasma gelsolin (GSN) at a ratio of 1 GSN:50 actin monomers. A total of 5 nM filaments was mixed with SALS protein at different concentrations, and the rate of actin assembly was followed by the addition of 1 mM pyrene actin. sals Mutant Sarcomeres Have Short Thin Filaments To investigate the organization of sarcomeres in sals mutant muscle myofibrils, we dissected WT and sals mutants at 19-21 hr AEL, and stained muscles with phalloidin as well as antibodies targeting a number of sarcomeric markers ( Figures 4A-4D ). These include Drosophila muscle Myosin Heavy Chain (MHC) ( Figure 4A) ; KZ, an isoform of the Drosophila Titin homolog Sallimus (SLS) localized at the Z line (Machado et al., 1998 ) ( Figure 4B) ; Tropomyosin (TM) ( Figure 4C ); and Tmod ( Figure 4D ).
The overall distribution of these sarcomeric components, except Tmod, appeared to be unaltered in the sals-deficient myofibrils ( Figures 4A-4D ). Whereas Tmod staining was found in or close to the M line of the sarcomere in WT myofibrils, its distribution was very close to the Z line in mutants ( Figure 4D ). Furthermore, the length of thin filaments was much shorter in mutant sarcomeres (0.85 ± 0.021 mm versus 2.75 ± 0.086 mm [range from 1.8 to 3.4 mm] in WT; myofibrils in body wall muscle VL3 in A3 or A4 were analyzed; n R 12). The reduced size of thin-filament lengths found in mutant myofibrils was very similar to that of sals-deficient myofibrils in primary culture (data not shown). Short thin-filament lengths were independently confirmed by phalloidin staining for F-actin (Figure 3) and by staining for TM ( Figure 4C) . Notably, the width of MHC staining in mutant myofibrils, although slightly shorter, was comparable to that in WT ( Figure 4A ), suggesting that the thick-filament length was not dramatically reduced. Altogether, these results indicate that SALS is not critical for the normal organization of several sarcomeric proteins, but that it is essential for achieving the final thin-filament length. This conclusion was further supported by an EM analysis of sals mutant muscles, which had well-organized myofibril structures at 20-22 hr AEL, as revealed in both transverse and longitudinal EM sections (Figures 4E-4H) .
SALS Binds Both G-Actin and F-Actin and Associates with Filament Pointed Ends
As SALS (referred to as ''the long form of SALS'' in the text below) has a predicted actin-binding domain, we determined whether it could bind actin. We first examined whether SALS could directly bind to G-actin in vitro. Because the full-length GST-SALS protein is not expressed well, we tested two complementary fusion proteins, SALS(386-513) and SALS(477-596), in a pull-down assay.
SALS(386-513), which contains the two WH2 domains, bound G-actin, whereas SALS(477-596), which lacks the WH2 domains, did not ( Figure 5A ). This suggests that the WH2 domains of SALS are sufficient for G-actin binding.
We further evaluated the capacity of SALS to bind to actin filaments (F-actin) by using a cosedimentation assay. The purified recombinant SALS protein by itself did not sediment at 200,000 3 g (30 min). However, SALS cosedimented with gelsolin-capped F-actin ( Figure 5B ), indicating that SALS binds F-actin through the pointed ends and/ or sides, but not through the barbed ends, which were capped by gelsolin in the assay (Yin et al., 1981) . The association of SALS with F-actin is specific, because the control protein GST failed to sediment with F-actin (data not shown).
To investigate SALS pointed-end effects, we determined whether it affected actin elongation from gelsolincapped actin filaments. As shown in Figure 5C , we found that SALS markedly slowed the rate of addition of actin subunits at the pointed end of these capped, but not uncapped, filaments. The effect was observed at a stoichiometry that also eliminates monomer sequestration as a mechanism of diminished pointed-end assembly. Altogether, our data suggest that SALS is associated with the filament pointed ends.
SALS Protein Is Enriched at Pointed Ends during Thin-Filament Elongation
To further characterize the role of SALS in sarcomere elongation, we examined its localization pattern in muscles by using two antibodies targeting two different regions of SALS. Both antibodies showed an identical staining pattern in muscles, and this pattern revealed that SALS is specifically associated with thin filaments, but not with thick filaments (data not shown). Because new sarcomeres are constantly added to myofibrils during muscle growth through three larval stages (L1, L2, L3) (Haas, 1950) , we examined SALS localization in late-L2 or early-L3 muscles because they are more easily prepared for visualization.
We investigated the SALS localization pattern with respect to F-actin (by phalloidin staining) and to Tmod (Figures 5D-5G) , as well as to a-actinin ( Figure S5 ) in somatic body wall muscles. We detected a large variation in thin-filament morphology among different sarcomeres within the same myofibril, although the lengths of these sarcomeres were relatively uniform ( Figures 5D-5G ). Phalloidin has been reported to have less accessibility to more organized thin filaments, due to their association with actin-binding thin-filament pointed ends protrude out, forming ragged ends toward the middle of the sarcomere (arrows). proteins such as nebulin, which may block phalloidin from binding to F-actin (Zhukarev et al., 1997) . Thus, we determined the level of organization of thin filaments in sarcomeres based on the phalloidin staining pattern: those with broad, fuzzy staining were the least organized (top panels in Figures 5E and 5F ), and those with strong, Z line staining were the most organized and usually had the longest length, with their pointed ends meeting in the middle of the sarcomere as a discrete band ( Figure 5G ). Interestingly, sarcomeres with less organized thin-filament morphology were often detected at the muscle termini ( Figures 5D and 5E) , where growth is known to take place in vertebrate muscles (Dix and Eisenberg, 1990; Williams and Goldspink, 1971) . By analogy, we presume that such sarcomeres represent newly formed sarcomeres, whereas those with a more organized thin-filament morphology are older and full-grown sarcomeres.
The distribution of a-actinin, a marker for thin-filament barbed ends at the Z line, was always located in the midline of the phalloidin staining ( Figure S5 ), confirming that thin filaments are relatively stable at the barbed ends (Littlefield et al., 2001 ). In contrast, several patterns of Tmod and SALS localization could be distinguished and correlated with the morphology of thin filaments in sarcomeres (middle panels in Figures 5E-5G ). Importantly, SALS was localized at the pointed ends of thin filaments while they were elongating ( Figures 5E, 5F , and 5H), but it disappeared from the pointed ends of full-grown thin filaments and relocated at the region flanking the Z line, where the fuzzy Tmod staining pattern was also observed [Figures 5G and 5H] . This doublet pattern was more obvious in myofibrils of visceral muscles of third-instar larvae ( Figure S5B) . A similar distribution pattern has also been observed previously for MLP (Muscle LIM protein), a protein implicated in myofibril growth (Arber et al., 1997) . Because sals-deficient muscles also have thin myofibrils, we speculate that this doublet pattern flanking the Z lines may represent the sites at which newly assembled thin filaments are located, which may also contribute to the transverse growth of myofibrils. Notably, Tmod distribution was not found at the tip of thin-filament ends in, presumably, newly added sarcomeres, but these were the loci at which the strong SALS staining was observed (arrows in Figure 5E ). Thus, we speculate that these ends may not be capped strongly by Tmod while they are still actively elongating, most likely through SALS activity.
Importantly, SALS is also expressed in the adult fly indirect flight muscles (IFM) ( Figure 5I ). The IFM increase their size by the synchronous lengthening of sarcomeres (from 1.7 mm to 3.2 mm), whereas the sarcomere number remains unchanged in myofibrils (Reedy and Beall, 1993) . This is unlike larval muscles, which grow by increasing sarcomere number through the addition of newly assembled sarcomeres to the existing myofibrils. Thus, IFM provide a better system by which to correlate the positions of SALS to the growth of thin filaments. Indeed, we observed strong localization of SALS at the pointed ends when the thin filaments were still elongating along with sarcomere lengthening in the IFM 72 hr after pupal formation (APF) ( Figure 5I ). Furthermore, SALS is less enriched at the pointed ends when thin filaments reach their maximum length, because sarcomere lengthening stops in the IFM of 2-day-old adults ( Figure 5I) . Altogether, the distribution of SALS in both larval muscles and adult IFM suggests that SALS may be involved in thin-filament elongation from the pointed ends.
SALS Is Required for GFPactin Incorporation at Pointed Ends
To provide further support for the pointed-end activity of SALS, we established primary cell cultures from myoblasts isolated from embryos carrying the Dmef2-Gal4, UAS-GFPactin transgenes. In these cells, GFPactin was expressed at the stage at which myofibril assembly just starts to occur. This unique timing of expression causes the initial incorporation of GFPactin into thin filaments to be found at both the Z line and the filament pointed ends, either in primary muscles cultured within 5 days at 18 C or in early-L1 muscles ( Figure 6A and data not shown). This is consistent with the report from Littlefield et al. (2001) that states that G-actin can be incorporated into both barbed and pointed thin-filament ends. However, after an extended period of culture, either in vivo (such as in third-instar larval muscles) or in primary culture (such as those cultured for 12 days at 18 C), GFPactin was found throughout the entire thin filaments, presumably due to turnover of non-GFP-labeled, endogenous actins and further incorporation of GFPactin (Roper et al., 2005 ; data not shown). We thus only examined the effects of dsRNAs targeting lacZ or sals on the initial sites of incorporation of GFPactin in the thin filaments of primary muscles cultured within 5 days at 18 C. Muscles in primary cultures treated with control lacZ dsRNA were similar to muscles in untreated cultures, and, in both cases, the majority displayed two incorporation sites for GFPactin ( Figures 6A and 6C ): one site colocalized with a-actinin at the Z line, where thin-filament barbed ends are located; the other site mapped to the middle of the sarcomere, at the thin-filament pointed ends. Unlike control primary muscles, the majority of sals RNAi primary muscles showed GFPactin incorporation only at the Z lines, with no incorporation at the pointed ends ( Figures 6B and 6C ). These data strongly indicate that SALS is required for GFPactin incorporation into pointed ends, but not barbed ends.
Converse Effect of SALS and Tmod on Thin-Filament Assembly
Given the decreased length of thin filaments observed in the absence of a functional SALS protein, we tested whether its overexpression could lead to a corresponding increase in thin-filament length. Constitutive expression of SALS in muscles disrupted their function, and 65% of embryos carrying Dmef2-Gal4, UAS-sals failed to hatch at 29 C (n = 200). The remaining, although able to hatch, crawled very slowly and later died. To obviate any complications resulting from the mechanical stress placed by other tissues on muscles in vivo, we examined muscle phenotypes in primary culture.
Primary muscle cells isolated from Dmef2-Gal4, UASsals embryos were cultured for 5 days at 29 C, fixed, and stained with phalloidin and the sarcomeric marker KZ. Strikingly, 90% of the primary muscles (n = 57) had completely lost the stereotypical striated pattern of thin and thick filaments ( Figure 7B ). This phenotype was reminiscent of that observed in primary muscles treated with a dsRNA against Tmod ( Figure 7A ; 80% penetrant, n = 40), suggesting that excess SALS or loss of Tmod may disrupt initial myofibril assembly (as indicated in the model shown in Figure 7J ). However, a small percentage of muscles with excess SALS (7%, n = 56) contained myofibrils with an aberrant striated pattern with longer than usual sarcomeres ( Figure 7E ), a phenotype that also could be found in Tmod dsRNA-treated primary myofibrils (5% penetrant) ( Figure 7D ), but never found in controls ( Figure 7C ). These mild phenotypes may reflect a relatively lower level of SALS expression or a partial reduction of Tmod level caused by RNAi in muscle cells, respectively. In the myofibrils containing elongated sarcomeres, staining for KZ or phalloidin revealed a relatively normal, striated Z line pattern, although localization of KZ was slightly altered (middle panels in Figures 7C-7E) . However, the staining for Tmod in the primary muscles with either Tmod RNAi or overexpression of SALS was diffuse and did not exhibit any regular striated pattern, as seen in controls (data not shown). Controls had a clear and discrete phalloidin staining band in the middle of the sarcomere, whereas phalloidin staining in the middle of these lengthened sarcomeres was fuzzy and irregular ( Figures 7C-7E ), showing that their thin filaments are misaligned and have variable lengths, and that some extend across the M line, resulting in no obvious H zone. This observation indicates that excess SALS can cause thin filaments to elongate from the pointed ends.
The antagonistic activities of SALS and Tmod suggest that they might genetically interact in the thin-filament assembly process. To document this interaction, we first confirmed that excess Tmod would result in short thinfilament lengths in primary cultured muscles (1.8 ± 0.042 mm versus 2.5 ± 0.034 mm in controls; average ± SD, n R 15 primary muscles scored for each genotype), as previously reported to be the case in vertebrate muscles and in fly IFM (Littlefield et al., 2001; Mardahl-Dumesnil and Fowler, 2001) (Figures 7G and 7H ). In addition, animals overexpressing Tmod had much higher mortality rates at both embryonic and larval stages compared to the control animals carrying Dmef2-Gal4 alone ( Figure 7F ), due to muscle defects resulting from short thin-filament lengths (data not shown). Importantly, reduction of the SALS level enhanced the effect caused by Tmod overexpression, as demonstrated by an increase in embryonic mortality rate ( Figure 7F ) and a greater reduction in thin-filament lengths in cultured muscles (Figures 7G-7I) . Thus, we conclude that Tmod and SALS functionally antagonize each other in thin-filament assembly at the filament pointed ends.
DISCUSSION SALS Promotes Thin-Filament Elongation from Pointed Ends In Vivo
In this study, we report the characterization of SALS, an actin-binding, WH2-domain-containing protein that is essential for the development and function of Drosophila larval muscles. Importantly, we show that SALS is required for the elongation of thin filaments from pointed ends to attain their final lengths in sarcomeres. These conclusions are based on the findings that (1) inactivation of SALS by either RNAi or genetic disruption leads to myofibrils containing shortened thin filaments, (2) the localization of SALS at the filament pointed ends coincides with the growth of thin filaments, (3) GFPactin fails to incorporate shorter than that found in UAS-Tmod/+;Dmef2-Gal4/+ primary muscles (1.6 ± 0.079 mm versus 1.8 ± 0.042 mm; average ± SD, n R 15).
into thin filaments through pointed ends in the absence of SALS, and (4) SALS overexpression is sufficient to cause overgrowth of thin filaments. The discovery of SALS is significant because it demonstrates the existence of a protein that appears to promote thin-filament elongation from pointed ends in vivo. Our genetic analyses suggest that SALS may act by antagonizing Tmod pointed-end capping activity ( Figure 7J) . The antagonism may resemble that observed between Ena/VASP proteins and the capping protein (Bear et al., 2002) or between formins and the capping protein (Zigmond et al., 2003) at the barbed end. Loss of SALS would allow Tmod to cap the pointed ends permanently. This is equivalent to the effect of an increase in Tmod levels during myofibril assembly, which converts Tmod from a dynamic to a permanent cap by outcompeting SALS at the pointed end and by preventing SALS from elongating actin filaments. Conversely, overexpression of SALS leads to a phenotype similar to loss of Tmod, because excess SALS might act as an ''anticapping'' protein to compete with and antagonize Tmod access to the filament pointed ends. Finally, the complex localization patterns of Tmod and SALS, together with their antagonistic relationships, is suggestive of the mechanism deployed during normal thin-filament assembly. Indeed, rapid actin assembly at the uncapped filament pointed ends is consistent with the localization of Tmod that lags behind SALS ( Figure 5 ).
As a protein that binds both G-actin and F-actin, SALS may function by stabilizing F-actin and/or through the direct involvement of actin polymerization. To our surprise, although it is strongly associated with the pointed ends, SALS alone appears to inhibit filament elongation in vitro ( Figure 5 ), instead of promoting elongation, as supported by all of the in vivo data. This discrepancy may imply that other factors such as Tmod, TM, and profilin-actin are needed in the biochemistry assay to observe the effect of SALS in vitro. Indeed, the long form of SALS contains Pro-rich profilin-binding sequences positioned immediately N-terminal to the two tandem actin-binding WH2 domains. Moreover, crystal structure analysis suggests that the Prorich regions preceding WH2 domains may facilitate actinfilament elongation by increasing the local concentration of profilin-actin, or that they may mediate actin monomer transfer directly to WH2 via profilin (Chereau et al., 2005) .
How Does Lack of SALS Lead to Shortened
Sarcomere Length and Increased Sarcomere Number in Myofibrils? Our analysis of sals mutant muscles suggests that the ''short sarcomere'' phenotype is a consequence of shortened thin filaments. This model is consistent with previous findings that reduced sarcomere lengths are found in muscles with altered expressions of proteins known to be involved in the regulation of actin-filament lengths, for instance when Tmod is present in excess (Sussman et al., 1999) . Furthermore, we propose that sarcomere length may be specified during assembly in order to achieve maximum actomyosin interaction. Based on the crossbridge contraction theory (Huxley and Simmons, 1971) , force generation and motion in striated muscle result from interactions between thin and thick filaments through the cyclical formation and rupture of the actomyosin bonds that act as crossbridges in the overlap region of the two filaments in sarcomeres. Previous studies have shown that there exists a relationship between actomyosin bonds and sarcomere length whereby sarcomere length decreases with an increase in actomyosin bonds and vice versa (Telley and Denoth, 2007) . Thus, we speculate that if the sarcomere length remained the same in sals mutant myofibrils as in WT, the overlap between the myosin and shortened actin filaments would be severely reduced, completely impairing muscle function. Based on these considerations, we speculate that sals mutant myofibrils may compensate for this problem by adopting a shorter sarcomere length, thereby restoring a more optimal level of actomyosin interaction.
Moreover, we propose that the mechanical constraints placed on a muscle in vivo can explain the intriguing difference in sarcomere length that we observe in mutant sals muscles in vivo compared to those grown in culture. As we report, absence of SALS leads to 70% shortening of the sarcomeres in the myotubes in culture (Figure 1 ), but to only a 27% reduction in sarcomere length in muscles in vivo (Figures 3 and 4) . Because the sarcomeres are presumably contracting under a much heavier load in vivo compared to myofibrils grown in culture, we reason that sals mutant sarcomeres are not able to shorten as much in vivo as they do in culture. We also note that such dramatic difference cannot be attributed to the age difference between muscles of 22 hr-old sals mutant embryos and those of R5 day-old sals mutant muscles in culture, since there is no difference in sarcomere length between WT embryonic and larval muscles.
In addition, sals mutant myofibrils grown in primary cultures showed an increase in sarcomere number, resulting in mutant myofibrils with a length similar to their WT counterparts. Here again, the increase in sarcomere number may reflect a compensatory mechanism intended to achieve a strength of contraction comparable to that of WT myofibrils. Indeed, shortened sarcomeres, which have reduced actomyosin compared to WT sarcomeres, may not be as efficient as a single contractile unit. Thus, the addition of more such sarcomeres to a myofibril might restore better functionality. This compensatory addition of (J) Model of thin-filament assembly steps under conditions of either no SALS, normal SALS, or excess SALS. The final length of thin filaments is attained in a two-step process. Short thin filaments can form under no SALS conditions (step 1), whereas longer thin filaments are achieved only in the presence of SALS (step 2). However, excess SALS, depending on the timing and its dosage, can either disrupt sarcomere organization or increase thin-filament length within sarcomeres. The scale bar is 30 mm in (A) for (A) and (B), 10 mm in (C) for (C)-(E), and 10 mm in (G) for (G)-(I).
Developmental Cell 13, 828-842, December 2007 ª2007 Elsevier Inc. 839 Developmental Cell sarcomeres probably also occurs in sals mutant myofibrils in vivo. Indeed, muscles of sals mutant larvae at 28-30 hr AEL had many more sarcomeres (18 compared to 12 in age-matched controls). However, the muscle length was much shorter (only 70% of their WT counterparts) at this stage, indicating that mutant muscles with shortened sarcomeres may grow much more slowly than in WT at the same stage. Moreover, from 28-30 hr AEL onward, sals mutant muscles were completely disrupted, and mutant animals eventually died. This is probably due to mechanical stresses placed on the muscle by other tissues during development. We speculate that the force generated by sals mutant muscles of a shorter size may not be strong enough to sustain these mechanical stresses in vivo, and the mutant animals died long before their muscles could achieve the same length as in WT. This is in contrast to the sals mutant muscle in culture, which is able to attain a final muscle length similar to WT controls while still maintaining normal striated morphology after being cultured for a long period of time, most likely due to the lack of the mechanical stresses present in the whole animal.
A Two-Step Model of the Thin-Filament Assembly Process Thin filaments are still assembled in the absence of SALS, although their length is significantly shortened, indicating that SALS is not required for initial thin-filament assembly ( Figures 1B and 4) . However, SALS is absolutely required for thin filaments to attain a longer length, and we show that SALS promotes thin-filament lengthening from pointed ends (Figures 5 and 6 ). These data reveal a twostep process of thin-filament assembly in Drosophila larval muscles ( Figure 7J ). During step 1, short filaments are assembled, whereas during step 2, which depends on SALS activity, the filaments expand to their final lengths from their pointed ends ( Figure 7J ). actin RNAi presumably disrupts both thin-filament assembly steps. Thus, actin RNAi primary muscles contain both shortened sarcomeres that have thin filaments that fail to elongate and shortened myofibrils that fail to grow longitudinally through the addition of more sarcomeres, whose assembly presumably requires assembly of short thin filaments (step 1). In contrast, sals RNAi only disrupts the second elongation step, but it still allows the addition of short sarcomeres containing short thin filaments to preexisting myofibrils to attain normal myofibril length. A similar two-step process has also been implicated in myofibril assembly of the fly adult IFM (Mardahl-Dumesnil and Fowler, 2001 ). Although we are not yet able to efficiently disrupt SALS function to examine its role in IFM thin-filament assembly, SALS is most likely involved, because it is localized at the pointed ends of elongating thin filaments during IFM development ( Figure 5 ).
Possible SALS Activity in Vertebrate Striated
Muscle and Nonmuscle Cells Studies on myofibrillogenesis in vertebrate striated muscles also suggest a similar two-step process in thin-filament assembly. For example, during early myofibrillogenesis in the chick cardiac myoctyes, sarcomeres grow from 1.5 mm to 1.8-2.5 mm, and their thin filaments elongate accordingly (Gregorio and Antin, 2000) . Delayed assembly of Tmod at pointed end was thought to contribute to this elongation process (Gregorio et al., 1995) . In addition, inhibition of Tmod activity in these cells causes excessive thin-filament elongation into H zones (Gregorio et al., 1995) . These newly assembled filaments from uncapped pointed ends are unlikely to result from the sole modulation of the function of currently known proteins such as TM or cofilin, which maintain thin-filament length by stabilizing filaments and/or inhibiting their depolymerization from pointed ends (Littlefield and Fowler, 1998) . Because these proteins only limit existing filament size, but do not contribute to actin assembly (Iwasa and Mullins, 2007) , efficient pointed-end assembly is likely to involve a SALSlike activity.
SALS-like activity is unlikely to play a role in actin assembly in cellular processes that require actin filaments to turn over rapidly, such as protrusion of the leading edge of lamellipodia, where the pointed ends are the sites for rapid filament disassembly. However, it may be important for length specification of stable actin-filament structure that requires regulation of actin assembly from pointed ends, such as in hair cell rootlets of chick cochlea (Tilney and DeRosier, 1986) . Thus, even though BLAST searches failed to identify any close SALS orthologs in vertebrates, functionally related proteins are likely to exist. There are several uncharacterized WH2-containing proteins present in human and mouse genomes (Paunola et al., 2002) , and one or more of these may regulate actin-filament lengthening from pointed ends.
EXPERIMENTAL PROCEDURES
Drosophila Genetics Drosophila strains used in this study were Dmef2-Gal4 (Ranganavakulu et al., 1996) ; UAS-GFPactin57B (Roper et al., 2005) ; TTG (TM3, Twi-Gal4, UAS-2EGFP, Ser) and twi ID96 (from Dr. A Michelson); (Thibault et al., 2004) ; and Df(3R)MKx1 (from the Bloomington Drosophila Stock Center). w 1118 was used as a control strain. Excision of the piggyBac element from PBac{WH}f07849 was done as described (Thibault et al., 2004) .
P{PZ}tho[1], PBac{WH}f07849
Embryonic Primary Cell Cultures and Primary Cell RNAi
Embryonic primary cell cultures were established mainly as described (Bernstein et al., 1978) . Cells were seeded and grown either in 384-well optically clear plates (Costar) (in Figure 1B ) or in LabTek 8-well chamber coverglass slides (VWR) coated with human vitronectin (Chemicon) (Volk et al., 1990 ) (used for culturing of primary muscles shown in the insets of Figure 1B and in Figures 6 and 7) , at 1.7-2.5 3 10 5 cells/cm 2 . Mature primary muscles used for analyses were usually from 12-day cultures at 18 C or from 5-day cultures at 25 C or 29 C.
A detailed description of the establishment of the primary cell RNAi protocol will be described elsewhere. Briefly, the primary cells were isolated from postgastrula embryos (4-6 hr AEL) and were seeded in plates containing dsRNAs at around 4 3 10 4 cells per well. After 22 hr in serum-free M3 medium, additional serum-containing culture medium was added to bring the solution to a final concentration of 10% FCS. After an additional 11 days of culturing at 18 C, primary cells were directly fixed with 4% formaldehyde (Polyscience, Niles, USA). dsRNAs were prepared as described at http://flyrnai.org/. The oligos for making dsRNAs used in this study can be found in the Supplemental Data.
Molecular Biology, Germline Transformation, In Situ Hybridization, and Antibody Production See the Supplemental Data.
Actin-Binding Assays and Actin-Polymerization Assay
The GST pull-down assays, cosedimentation assays, and pyrene actin-polymerization assay were carried out as described (MartinezQuiles et al., 2001 ). The actin assembly rate was measured as described (Pollard and Mooseker, 1981) . Details can be found in the Supplemental Data.
Immunofluorescence Microscopy and Image Analysis Late embryos or larvae were dissected in Ca
2+
-free saline buffer (relaxing buffer) as described (Budnik et al., 2006) . Myofibrils from dorsal longitudinal muscles of pupal and adult IFM were isolated as described (Mardahl-Dumesnil and Fowler, 2001 ). In general, dissected tissues and primary cells were fixed in 4% formaldehyde in relaxing buffer for 20-30 min, and the standard immunohistochemistry protocol was then followed (Budnik et al., 2006) . The stained samples were analyzed on a Leica LSM NT confocal microscope. Primary antibodies used in this study can be found in the Supplemental Data.
Analyses of myofibril features such as thin-filament length and sarcomere length were performed from deconvoluted images by using Leica confocal software TCS SP2. Thin-filament length was defined as half the distance between Tmod peaks or half the width of the phalloidin bands or the distance between Tmod and neighboring a-actinin peaks. Sarcomere length was defined as the distance between a-actinin bands or between midlines of the phalloidin bands.
Electron Microscopy
See the Supplemental Data.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, five figures, and movies and are available at http://www. developmentalcell.com/cgi/content/full/13/6/828/DC1/.
